Product NewsClinical Diagnostics Thermo Fisher receives FDA approval for NGS-based companion diagnostic for new NSCLC treatment
Product NewsLife Sciences Thermo Fisher NGS assay FDA-approved as companion diagnostic for ZEGFROVY and tumor profiling
B Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLCAvailable on-demandWatch on-demand
Industry News65% of eligible lung cancer patients do not receive the most appropriate targeted therapies, Diaceutics report finds
